期刊
ACTA NEUROPATHOLOGICA COMMUNICATIONS
卷 11, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s40478-023-01642-6
关键词
Pyrroloquinoline quinone (PQQ); Mitochondria; Metabolism; Metabolomics; ATP; Retinal ganglion cell; Retina; Optic nerve; Neuroprotection
Retinal ganglion cells require regulated metabolism and functional mitochondria to maintain ATP levels and cell viability. Alterations in metabolism and mitochondrial processes are early indicators of optic neuropathies. PQQ, a quinone cofactor, has potential neuroprotective effects and can affect cellular and mitochondrial metabolism, but its mechanisms need to be further studied.
Retinal ganglion cells are highly metabolically active requiring strictly regulated metabolism and functional mitochondria to keep ATP levels in physiological range. Imbalances in metabolism and mitochondrial mechanisms can be sufficient to induce a depletion of ATP, thus altering retinal ganglion cell viability and increasing cell susceptibility to death under stress. Altered metabolism and mitochondrial abnormalities have been demonstrated early in many optic neuropathies, including glaucoma, autosomal dominant optic atrophy, and Leber hereditary optic neuropathy. Pyrroloquinoline quinone (PQQ) is a quinone cofactor and is reported to have numerous effects on cellular and mitochondrial metabolism. However, the reported effects are highly context-dependent, indicating the need to study the mechanism of PQQ in specific systems. We investigated whether PQQ had a neuroprotective effect under different retinal ganglion cell stresses and assessed the effect of PQQ on metabolic and mitochondrial processes in cortical neuron and retinal ganglion cell specific contexts. We demonstrated that PQQ is neuroprotective in two models of retinal ganglion cell degeneration. We identified an increased ATP content in healthy retinal ganglion cell-related contexts both in in vitro and in vivo models. Although PQQ administration resulted in a moderate effect on mitochondrial biogenesis and content, a metabolic variation in non-diseased retinal ganglion cell-related tissues was identified after PQQ treatment. These results suggest the potential of PQQ as a novel neuroprotectant against retinal ganglion cell death.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据